Early-stage biotech investor 5AM ready to roll on new fund worth $250m.
California-based investor 5AM Ventures has raised its fourth round, worth $250m, with early-stage biotechs in its crosshairs. The company is looking to back around 15 companies seeking series A funding with the war chest, following a similar fund for $159.2m raised in 2009. The venture investor has been active in backing university spin-outs, notably Yale…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
